European Basic Pharmaceutical Products and Pharmaceutical Preparations Output by Country

In 2023, Switzerland held the largest share of European Basic Pharmaceutical Products and Pharmaceutical Preparations output at 8%, with a significant year-on-year increase of 3%. Denmark followed with a 3.8% share and the highest increase at 4.16%. Slovenia, Belgium, and Hungary also contributed substantially, with Belgium seeing a notable rise of 5.15%. Spain and Greece experienced the highest growth rates at 7.39% and 8.45%, respectively.

Over the past five years, the compound annual growth rate (CAGR) highlights dynamic shifts within the industry. Continued growth in advanced economies like Switzerland, Denmark, and Belgium underscores their strong pharmaceutical infrastructure. In contrast, countries like Bulgaria and Croatia saw declines, indicating a potential shift or re-evaluation in their pharmaceutical sectors.

Future trends to watch for include increased innovation in biotechnological pharmaceuticals, the impact of regulatory changes, and the growing role of digital health technologies. Enhanced R&D investments and collaborations among European countries are likely to drive further growth and output in the pharmaceutical sector.